The following is a collection of current COVID-19 vaccine resources pertaining to myasthenia gravis from external organizations. This article is intended to provide the reader with general, updated information. It is not meant to be used as a substitute for medical advice. Should you have questions about the vaccine regarding your personal health and care plan, please consult your physician and medical providers.
COVID-19 & Myasthenia Gravis Resource List
The following resources are in alphabetical order.
Last Updated on December 16th, 2020
Brain and Life Magazine
Center for Disease Control & Prevention (CDC)
Food & Drug Administration (FDA)
George Washington University School of Medicine & Health Sciences
Presentation by: Hana Axelrod, MD, MPH, Henry J. Kaminski, MD, & Helen Girma
International MG/COVID-19 Working Group
"...because most patients with MG are on immunosuppressive or immunomodulatory therapies and may also have respiratory muscle weakness, there is a theoretical concern that MG/LEMS patients may be at higher risk of contracting the infection or experiencing severe manifestations of COVID-19."
Muscular Dystrophy Association (MDA)
Myasthenia Gravis Foundation of America (MGFA)
Myasthenia Gravis News
We will continue to update this list as we gather more information regarding the COVID-19 vaccines and myasthenia gravis.